Th2 cell modulators (AstraZeneca)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameTh2 cell modulators (AstraZeneca)
Drug Alias NameTh2 cell project (Astra Draco)Th2 cell modulators (Astra Draco)Th2 cell project (AstraZeneca)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionT lymphocytes modulators
TargetsUpdating
Therapy Area/IndicationsDermatitis, AtopicAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAstra Draco AB
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAstra Draco ABAstrazeneca Plc
Active IndicationsN/A
Inactive IndicationsDermatitis, AtopicAsthma

Other Information

ATC CodeN/A
Related LinksN/A